A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Clinical trial NCT04219254 · RECRUITING

Trial details

NCT number: NCT04219254
Sponsor: BioInvent International AB
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2020-06-29
Primary completion: 2027-11-01
Enrollment: 197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.